|
10 Jan 2007 |
Aida Pharmaceuticals Receives Approval and Commences Phase II Trials of Potential Cancer Treatment
|
|
10 Jan 2007 |
XOMA Initiates Clinical Trial of NEUPREX At Harvard Medical School in Allogeneic Hematopoietic Stem Cell Transplantation
|
|
09 Jan 2007 |
Alkermes and Lilly Expand AIR(R) Inhaled Insulin Collaboration
|
|
09 Jan 2007 |
Æterna Zentaris Initiates First Study of Phase 3 Program with Cetrorelix in BPH - 600 Patient Trial Conducted in the United States and Canada
|
|
09 Jan 2007 |
Allon drug selected for clinical trial in the treatment of cognitive impairment in schizophrenia
|
|
09 Jan 2007 |
ThromboGenics Initiates Phase IIb U.S. Clinical Trial of Microplasmin in Vitrectomy
|
|
08 Jan 2007 |
Catalyst Biosciences And Wyeth Pharmaceuticals Sign Two Agreements For Novel Biotherapeutic Platform Of Engineered Proteases
|
|
05 Jan 2007 |
Nuvelo Initiates Phase 2 Trial of rNAPc2 in Patients with Metastatic Colorectal Cancer
|
|
05 Jan 2007 |
BioAxone Therapeutic Licenses Phase II Spinal Cord Injury Drug Cethrin(R) to Boston Life Sciences
|
|
04 Jan 2007 |
FDA Approves BYETTA(R) (exenatide) Injection for Expanded Combination Use
|
|
04 Jan 2007 |
Spectrum Pharmaceuticals Announces FDA's Acceptance of Ozarelix IND and Approval of Phase 2b Protocol in BPH (Benign Prostate Hypertrophy)
|
|
04 Jan 2007 |
CoGenesys Files to Begin Clinical Trials of Neugranin for the Prevention of Infections in Cancer Patients
|
|
04 Jan 2007 |
Five Prime enters Osteoarthritis and Pulmonary Fibrosis Collaboration with Centocor
|
